Westside Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9K | Sell |
66
-153
| -70% | -$39.2K | ﹤0.01% | 739 |
|
|
2025
Q1 | $49.2K | Hold |
219
| – | – | 0.01% | 408 |
|
|
2024
Q4 | $50.3K | Hold |
219
| – | – | 0.01% | 406 |
|
|
2024
Q3 | $53.7K | Hold |
219
| – | – | 0.01% | 395 |
|
|
2024
Q2 | $42.1K | Hold |
219
| – | – | 0.01% | 411 |
|
|
2024
Q1 | $43.5K | Hold |
219
| – | – | 0.01% | 397 |
|
|
2023
Q4 | $37.8K | Hold |
219
| – | – | 0.01% | 398 |
|
|
2023
Q3 | $32.5K | Hold |
219
| – | – | 0.01% | 408 |
|
|
2023
Q2 | $48K | Hold |
219
| – | – | 0.01% | 358 |
|
|
2023
Q1 | $48.1K | Hold |
219
| – | – | 0.01% | 360 |
|
|
2022
Q4 | $45 | Hold |
219
| – | – | ﹤0.01% | 423 |
|
|
2022
Q3 | $47 | Hold |
219
| – | – | ﹤0.01% | 415 |
|
|
2022
Q2 | $46 | Hold |
219
| – | – | ﹤0.01% | 413 |
|
|
2022
Q1 | $53 | Hold |
219
| – | – | ﹤0.01% | 409 |
|
|
2021
Q4 | $57 | Hold |
219
| – | – | ﹤0.01% | 390 |
|
|
2021
Q3 | $57 | Hold |
219
| – | – | ﹤0.01% | 382 |
|
|
2021
Q2 | $54 | Hold |
219
| – | – | ﹤0.01% | 377 |
|
|
2021
Q1 | $42 | Buy |
219
+1
| +0.5% | – | ﹤0.01% | 390 |
|
|
2020
Q4 | $46 | Hold |
218
| – | – | ﹤0.01% | 350 |
|
|
2020
Q3 | $37 | Buy |
218
+1
| +0.5% | – | ﹤0.01% | 370 |
|
|
2020
Q2 | $41 | Hold |
217
| – | – | ﹤0.01% | 344 |
|
|
2020
Q1 | $32 | Buy |
+217
| New | +$32 | ﹤0.01% | 367 |
|
|
2019
Q2 | $26 | Buy |
+215
| New | +$26 | ﹤0.01% | 374 |
|
|
2018
Q4 | $24.4K | Buy |
214
+2
| +0.9% | +$228 | 0.01% | 364 |
|
|
2018
Q3 | $24.6K | Sell |
212
-1
| -0.5% | -$116 | 0.01% | 326 |
|
|
2018
Q2 | $22.1K | Buy |
213
+2
| +0.9% | +$207 | 0.01% | 393 |
|
|
2018
Q1 | $20.3K | Hold |
211
| – | – | 0.01% | 386 |
|
|
2017
Q4 | $18.6K | Buy |
211
+1
| +0.5% | +$88 | 0.01% | 420 |
|
|
2017
Q3 | $16K | Buy |
210
+1
| +0.5% | +$76 | 0.01% | 442 |
|
|
2017
Q2 | $16.1K | Hold |
209
| – | – | 0.01% | 421 |
|
|
2017
Q1 | $14.4K | Buy |
209
+2
| +1% | +$138 | 0.01% | 415 |
|
|
2016
Q4 | $13.3K | Buy |
+207
| New | +$13.3K | 0.01% | 343 |
|